Montana § 50-12-102 Definitions

Montana Statutes

§ 50-12-102 — Definitions

Montana § 50-12-102

Title 50HEALTH AND SAFETY

Ch. 12TREATMENTS FOR CHRONIC OR TERMINAL ILLNESS

Part 1Right to Try Act

This text of Montana § 50-12-102 (Definitions) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 50-12-102 (2026).

Text

50-12-102 . Definitions. As used in this part, the following definitions apply:

(1)"Experimental treatment" means the provision of a medical intervention by a health care provider involving an investigational drug, biological product, device, or other treatment that has successfully completed phase 1 of a clinical trial but has not yet been approved for general use by the United States food and drug administration and either:

(a)remains under investigation in a clinical trial approved by the United States food and drug administration; or

(b)has a demonstrated safety record through documented clinical evidence from a qualified medical institution as defined by department rule.

(2)"Experimental treatment center" has the same meaning as provided in 50-5-101 .

(3)"Health care facility" ha

Free access — add to your briefcase to read the full text and ask questions with AI

50-12-102 . Definitions. As used in this part, the following definitions apply:
(1) "Experimental treatment" means the provision of a medical intervention by a health care provider involving an investigational drug, biological product, device, or other treatment that has successfully completed phase 1 of a clinical trial but has not yet been approved for general use by the United States food and drug administration and either:
(a) remains under investigation in a clinical trial approved by the United States food and drug administration; or
(b) has a demonstrated safety record through documented clinical evidence from a qualified medical institution as defined by department rule.
(2) "Experimental treatment center" has the same meaning as provided in 50-5-101 .
(3) "Health care facility" has the same meaning as provided in 50-5-101 . The term includes an experimental treatment center.
(4) "Health care provider" means any of the following individuals licensed pursuant to Title 37:
(a) a physician;
(b) an advanced practice registered nurse authorized by the board of nursing to prescribe medicine;
(c) a physician assistant; and
(d) a registered nurse performing services at an experimental treatment center.
(5) "Informed consent" means written documentation or digital recordation that meets the requirements of 50-12-105 .
(6) "Provider agreement" means a contract authorizing a health care provider to deliver an experimental treatment, or services related to the provision of an experimental treatment, under the supervision of an experimental treatment center's medical director.